Juan J Gomez-Reino
Overview
Explore the profile of Juan J Gomez-Reino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
143
Citations
5314
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Curtis J, Yamaoka K, Chen Y, Bhatt D, Gunay L, Sugiyama N, et al.
Ann Rheum Dis
. 2023 Jan;
82(3):331-343.
PMID: 36600185
Objectives: To evaluate malignancies and their associations with baseline risk factors and cardiovascular risk scores with tofacitinib versus tumour necrosis factor inhibitors (TNFi) in patients with rheumatoid arthritis (RA). Methods:...
2.
Salgado E, Romera-Baures M, Beltran-Catalan E, Naredo E, Carreira P, Garcia-Vivar M, et al.
Semin Arthritis Rheum
. 2021 Dec;
52:151920.
PMID: 34872742
Background: In immune-mediated inflammatory rheumatic diseases (IMIRD), there are differences between cis-men and cis-women in epidemiology, clinical feature, therapeutic approach, treatment response, and prognosis. In transgender individuals, information concerning IMIRD...
3.
Pombo-Suarez M, Sanchez-Piedra C, Garcia-Magallon B, Perez-Gomez A, Manrique-Arija S, Martin-Domenech R, et al.
Clin Rheumatol
. 2021 Apr;
40(10):3979-3988.
PMID: 33907904
Background: Retention of biological treatment provides a marker of drug effectiveness and patient satisfaction. Retention of golimumab was high in clinical trial extensions and real-world studies up to 5 years...
4.
Piera-Velazquez S, Wermuth P, Gomez-Reino J, Varga J, Jimenez S
Semin Arthritis Rheum
. 2020 Oct;
50(6):1226-1237.
PMID: 33059296
Numerous drugs and chemical substances are capable of inducing exaggerated tissue fibrotic responses. The vast majority of these agents cause localized fibrotic tissue reactions or fibrosis confined to specific organs....
5.
Ritchlin C, Giles J, Ogdie A, Gomez-Reino J, Helliwell P, Young P, et al.
ACR Open Rheumatol
. 2020 Sep;
2(10):543-554.
PMID: 32910531
Objective: Metabolic syndrome (MetS) is a cluster of concurrent risk factors for cardiovascular disease and type 2 diabetes. This post hoc analysis explored key efficacy and safety endpoints in patients...
6.
Mease P, Gladman D, Gomez-Reino J, Hall S, Kavanaugh A, Lespessailles E, et al.
ACR Open Rheumatol
. 2020 Jul;
2(8):459-470.
PMID: 32710493
Objective: Psoriatic arthritis (PsA) requires long-term treatment, yet safety concerns and monitoring requirements make maintenance a challenge. This analysis of pooled Psoriatic Arthritis Long-term Assessment of Clinical Efficacy (PALACE) 1,...
7.
Vela P, Sanchez-Piedra C, Perez-Garcia C, Castro-Villegas M, Freire M, Mateo L, et al.
Arthritis Res Ther
. 2020 Jun;
22(1):143.
PMID: 32539800
Objectives: To assess whether age, at the beginning of biologic treatment, is associated with the time a first adverse event (AE) appears in patients with rheumatoid arthritis (RA), ankylosing spondylitis...
8.
Franco-Trepat E, Alonso-Perez A, Guillan-Fresco M, Jorge-Mora A, Gualillo O, Gomez-Reino J, et al.
Expert Opin Ther Targets
. 2019 May;
23(7):607-618.
PMID: 31074669
: The rising prevalence of musculoskeletal pathologies in developed countries has caused a dramatic impact on social welfare. Amidst these musculoskeletal pathologies is Rheumatoid arthritis (RA), a chronic systemic autoimmune...
9.
Abad Hernandez M, Andreu J, Balsa Criado A, Diaz-Gonzalez F, Moreno Muelas J, Silva R, et al.
Reumatol Clin (Engl Ed)
. 2019 May;
17(3):160-169.
PMID: 31054806
In 2015 the Spanish Society of Rheumatology (Sociedad Española de Reumatología [SER]) published its position paper on biosimilar drugs. In this update, the SER, continues to manifest its unequivocal commitment...
10.
Ferreiro-Iglesias A, Montes A, Perez-Pampin E, Canete J, Raya E, Magro-Checa C, et al.
PLoS One
. 2019 Mar;
14(2):e0213073.
PMID: 30818333
Research in rheumatoid arthritis (RA) is increasingly focused on the discovery of biomarkers that could enable personalized treatments. The genetic biomarkers associated with the response to TNF inhibitors (TNFi) are...